|
|||||
|
|
LRRK2 and idiopathic Parkinson’s disease |
|
| Affiliation: | 1. Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA;2. Molecular Pharmacology Graduate Program, University of Pittsburgh, Pittsburgh, PA, USA;3. Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, The University of Alabama at Birmingham, Birmingham, AL, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |